- Live market news
- Stocks
- IVVD
Invivyd Inc.
IVVDStockUSA
Latest news on IVVDranked by Oyticker for market impact
- 15Impact
IVVD grants 157.5k inducement options to six new hires
Invivyd granted 157,500 aggregate options to six newly hired non-executive employees on October 1, 2026, under Nasdaq Rule 5635(c)(4) inducement provisions.
IVVDBiotechnology - 72Impact
Invivyd VYD2311 Shows Superior Safety vs. mRNA Vaccine in Phase 3 LIBERTY Study
Invivyd reported positive Phase 3 LIBERTY topline data showing VYD2311 monoclonal antibody demonstrated superior safety and tolerability compared to mRNA-based COVID-19 vaccine, with plans to pursue regulatory submission. The study also evaluated co-administration and immunologic interference.
IVVDBiotechnologyPharmaceuticalsHealthcare
SEC filings
All its filingsWhat IVVD filed
- 29 Sept 2026
- 1 Sept 2026
- 13 Aug 2026
- 13 Aug 2026
- 24 Jul 2026
- 6 Jul 2026
- 19 May 2026
- 14 May 2026
- 14 May 2026
Other event
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.